# <i>TP53, STK11</i> , and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/i-tp53-stk11-i-and-i-egfr-i-mutations-predict-tumor-immune-profile-and-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jérôme Biton,Audrey Mansuet‐Lupo,Nicolas Pécuchet,Marco Alifano,Hanane Ouakrim,Jennifer Arrondeau,Pascaline Boudou‐Rouquette,François Goldwasser,Karen Leroy,Jérémy Goc,Marie Wislez,Claire Germain,Pierre Laurent‐Puig,Marie‐Caroline Dieu‐Nosjean,Isabelle Cremer,Ronald Herbst,Hélène Blons,Diane Damotte |
| Citations | 367 |
| DOI | 10.1158/1078-0432.ccr-18-0163 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2803397860 |
| PMID | 29764856 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Marie Wislez](https://scholariq.org/researchers/marie-wislez/)
- [Hélène Blons](https://scholariq.org/researchers/helene-blons/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.